SMAD4 and familial pancreatic carcinoma: Collectively, the analyses show that PDX models can be valuable to identify copy number variations and clonal mutations of relevance (eg, SMAD4) and that the transcriptome is coming only from the pancreatic cancer cells and not from stroma.